Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 32Unknown 7Active not recruiting 7Withdrawn 5Recruiting 5Terminated 4

Sponsor Class

OTHER 4NETWORK 3INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 387Lung Neoplasms 310Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Leukemia, Lymphocytic, Chronic, B-Cell 168Myelodysplastic Syndromes 167Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

Zoledronic Acid 1Trastuzumab 1Pharmaceutical Preparations 1Paclitaxel 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × Carcinoma, Ductal, Breast × Clear all
NCT04088435 2023-05-12

Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

University of Louisville

Terminated
10 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT03560102 2021-10-22

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Kantonsspital Winterthur KSW

Phase NA Terminated
1 enrolled 7 charts
Breast

Carcinoma, Ductal, Breast

NCT01409811 2020-05-08

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid

City of Hope Medical Center

Phase NA Terminated
9 enrolled 3 charts
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01891357 2019-09-17

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

West German Study Group

Phase 2 Terminated
64 enrolled 7 charts
Breast

Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡